Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-21

Clinical Trial Update: Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intra-arterial chemotherapy for intraocular retinoblastoma was terminated; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Retinoblastoma | Phase 2 | Status: TERMINATED | Results posted: 2017-07-21